| ||||||||||||||||||||||||||||||||||
The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.
Section 4. Antimicrobial Agents and Related Therapy
MEDWATCHTHE FDA SAFETY INFORMATION AND ADVERSE EVENT REPORTING PROGRAM
MedWatch, the Food and Drug Administration (FDA) Safety Information and Adverse Event Reporting Program, is an outreach program for the health care system, including doctors, nurses, pharmacists, and patients, to enhance the effectiveness of the FDAs risk management activities for all regulated clinical medical products. These products include
Related Articles
Red Book 2003 2003: 37-49.
Red Book 2003 2003: 106-116.
Red Book 2003 2003: 472-486.